Message Font: Serif | Sans-Serif
No. of Recommendations: 0
IMGN says that it will probably lose money for some time to come to (justifiably) come out with a better product in the long run. Unfortuanetly; this means that they get cash from parternership deals from larger drug companies...while this is nice in the short run, it sounds as if they are giving up a (significant) level of future revenue for current cash requirements. assuming they get a good product, what prevents a significant portion of that money going to the big boys?
Print the post  


Live Video Event Monday!
The GP team is hosting a live video event on Monday at 4 p.m. ET. Don't worry if you can't make it — we'll have a replay and a transcript. Click for more!
When Life Gives You Lemons
We all have had hardships and made poor decisions. The important thing is how we respond and grow. Read the story of a Fool who started from nothing, and looks to gain everything.
Contact Us
Contact Customer Service and other Fool departments here.
Work for Fools?
Winner of the Washingtonian great places to work, and Glassdoor #1 Company to Work For 2015! Have access to all of TMF's online and email products for FREE, and be paid for your contributions to TMF! Click the link and start your Fool career.